Optimization Formula of Turmeric (Curcuma longa L.) Extract Chewable with Combination of Mannitol-Lactose as Filler Based on Simplex Lattice Design
Abstract
Hydroalcoholic extract of turmeric (Curcuma longa L.) doses of 1.66 mg/kg containing 10% of curcuminoid was recommended as a supplement for prevention of atherosclerosis. This study aimed to formulate hydroalcoholic extract of turmeric into chewable which are more acceptable and practical. Mannitol-Lactose selected as a filler to make the chewable in this study. Optimum composition of filler of the mixture obtained by the Simplex Lattice Design method.
Identification of turmeric rhizome has been done at Departemen of Plant Taxonomy, Faculty of Biology, Gadjah Mada University, Yogyakarta, Indonesia. The rhizome extraction carried out as re to research carried out by Quiles. The mixture between curcuminoid, ethanol and water extract made up to 25% level of curcuminoid level. Then, Extract was granulated with combination of filler mannitol-lactose to be five formulas, there are: FI (mannitol 100%), FII (mannitol-lactose 75%:25%), FIII (mannitol-lactose 50%:50%), FIV (mannitol-lactose 25%:75%), FV (lactose 100%). The granules then tested their physical properties such as flowability, compactibility, and water content. Furthermore, the granules tableted and physical tested including : weight uniformity, hardness, friability, absorption, flavor acceptance and soluble time. Determining the optimum formulation obtained from the physical properties of the granules and chewable physical properties based on SLD methods. Optimum formula of chewable then tested with kurkuminoid levels. The physical properties data of granules and chewable were analyzed statistically using student’s t-test.
The result of this study was the optimum formula obtained from the mixture of mannitol-lactose fillers with a ratio of 90% mannitol: 10% lactose. The optimum formula of turmeric extract chewable produced meets the physical properties of the granules and chewable. Acceptance of flavor chewable optimum formula appreciation in the range of sweet and sour taste to sour. Percentage kurkuminoid levels in chewable after manufacture process was 76.42%.
Full Text:
PDFReferences
Alderborn, G., and Nystrom, C., 1996, Pharmaceutical Powder Compaction Technology, 17 -18, Marcel Dekker Inc., New York.
Alderborn, G., 2002, Tablets and Compaction, dalam Aulton, M.E., (Ed.), Pharmaceutics The Science of Dosage Form Design, 2ndEd., 413, Churchill Livingstone, Edinburgh.
Armstrong, N.A., 2006, Mannitol, Asam Tartat, Magnesium Stearat, Gelatin, Laktosa, in Rowe, R.C., Sheskey, P.J., Owen, S.C., (Eds.), 2006, Hand Book of Pharmaceutical Excipients, 295-297, 385-394, 430-432, 449-453, 770-771 American Pharmaceutical Association, Washington DC.
Baley, G.J, Banker, G.S, Mc Curdy, V.E., and Peak, G.E., 1989, Tablet Formulation and Design, in Lieberman, H.A., Lachman, L., (Eds.), Pharmaceutical Dosage Forms : Tablets, Volume 1, 91-117, Marcel Dekker Inc., New York.
Backer, C. A., & Van Den Brink, R. B. C., 1965, Flora of Java, spermathophyta only, volume II, 607–608, N. V. P., Noordhooft, Groningen, Netherlands.
Banker, G.S., Anderson, N.R., 1986, Tablet, in Lachman L., Lieberman, H.A., Kanig, J.L., (Eds), The Theory and Practice of Industrial Pharmacy, 3th Ed., 683 – 703, Universitas Indonesia Press, Jakarta.
Bolton, S., 1997, Pharmaceutical Statistics: Practical and Clinical Aplication,3rd Ed., 610 – 619, Marcel Dekker, inc, New York.
Brittain, H.G., dan Newman, A. W., 1995, Particle Morphology : Optical and Electron Microscopies in Brittain, H. G., (Ed.), Physical Characterization of Pharmaceutical Solid, 140-141, Marcel Dekker, New York.
Czeisler, J.L., dan Perlma, K.P., Diluents dalam Boylan, J.C., and Swarbrick, J., (Eds), 1991, Encyclopedia of Pharmaceutical Technology, 57-60, Marcel Dekker, Inc., New York.
Fudholi, A., 2001, Teknologi dan Formulasi Sediaan Obat Bahan Alam dan Permasalahannya, Pharmacon, 2, (1), 25-33, Farmasi UMS, Surakarta
Quiles, J.L., M., César, L., Ramírez-Tortosa, Concepción M., Aguilera, Maurizio, Battino, Άngel Gil and M. Cermen Ramírez-Tortosa, 2002, Curcuma longa Extract Supplementation Reduces Oxidative Stress and Attenuates Aortic Fatty Streak Development in Rabbits, Arterioscler Thromb. Vasc. Biol. 2002;22;1225-1231.
Ramírez-Boscá, A., Alfonso, S., Miguel, A., Díaz-Alperi, J., August, B., Quintanilla, C., Eliseo, Q.A., and Jaime M., An Hydroalcoholic Extract of Curcuma longa Lowers the Apo B/apo A ratio Implication for Atherogenesis Prevention, Mechanisms of Ageing and Development, 2000; 119:41-47(1-2).
Sherma, J., and Fried, B., 1996, Handbook of Thin-Layer Chromathography, Revised and Expanded, Edisi II, 205-206, Marcell Dekker Inc., New York.
Tonnesen, H.H and Karlsen J., 1997, Recent Development In The Use of Curcumin As A Potential Drug, in Pramono, S., (ed):Recent development in curcumin pharmacochemistry : Proceeding of The International Symposium of Curcumin Pharmacochemistry (ISCP), August 29-31 1995,p.27-38, Aditya Media, Yogyakarta.
Refbacks
- There are currently no refbacks.